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The ability of E. coli strains to colonize the mouse large intestine has been correlated with their ability to
grow in cecal and colonic mucus. In the present study, an E. coli MG1655 strain was mutagenized with a
mini-Tn5 Km (kanamycin) transposon, and mutants were tested for the ability to grow on agar plates with
mouse cecal mucus as the sole source of carbon and nitrogen. One mutant, designated MD42 (for mucus
defective), grew poorly on cecal-mucus agar plates but grew well on Luria agar plates and on glucose
minimal-agar plates. Sequencing revealed that the insertion in MD42 was in the waaQ gene, which is involved
in lipopolysaccharide (LPS) core biosynthesis. Like “deep-rough” E. coli mutants, MD42 was hypersensitive to
sodium dodecyl sulfate (SDS), bile salts, and the hydrophobic antibiotic novobiocin. Furthermore, its LPS core
oligosaccharide was truncated, like that of a deep-rough mutant. MD42 initially grew in the large intestines of
streptomycin-treated mice but then failed to colonize (<102 CFU per g of feces), whereas its parent colonized
at levels between 107 and 108 CFU per g of feces. When mouse cecal mucosal sections were hybridized with an
E. coli-specific rRNA probe, MD42 was observed in cecal mucus as clumps 24 h postfeeding, whereas its parent
was present almost exclusively as single cells, suggesting that clumping may play a role in preventing MD42
colonization. Surprisingly, MD42 grew nearly as well as its parent during growth in undiluted, highly viscous
cecal mucus isolated directly from the mouse cecum and, like its parent, survived well after reaching stationary
phase, suggesting that there are no antimicrobials in mucus that prevent MD42 colonization. After mini-
mariner transposon mutagenesis, an SDS-resistant suppressor mutant of MD42 was isolated. The mini-mariner
insertion was shown to be in the bipA gene, a known regulator of E. coli surface components. When grown in
Luria broth, the LPS core of the suppressor mutant remained truncated; however, the LPS core was not
truncated when the suppressor mutant was grown in the presence of SDS. Moreover, when the suppressor
mutant was grown in the presence of SDS and fed to mice, it colonized the mouse large intestine. Collectively,
the data presented here suggest that BipA may play a role in E. coli MG1655 LPS core biosynthesis and that
because MD42 forms clumps in intestinal mucus, it is unable to colonize the mouse large intestine.
The large intestine of the mouse consists of the cecum and
the colon, each of which contains the mucosa and the luminal
contents. Two components of the mucosa are the layer of
epithelial cells on the intestinal wall and the mucus layer,
which covers them. The relatively thick (up to 400 m) mucus
layer consists of mucin, a 2-MDa gel-forming glycoprotein, and
a large number of smaller glycoproteins, proteins, glycolipids,
lipids, and sugars (1, 12, 18, 36, 39, 43, 45). Presumably, shed
epithelial cells are a source of many of the smaller mucus
components (36, 39). The mucus layer itself is in a dynamic
state, constantly being synthesized and secreted by specialized
goblet cells and degraded to a large extent by the indigenous
intestinal microbes (17, 32). Degraded mucus components are
shed into the intestinal lumen, forming a part of the luminal
contents which are excreted in feces (17).
The prevalent theory as to how bacteria colonize the mam-
malian gut is that the 500 indigenous species (31) can coexist
as long as each member of the flora is able to utilize one or a
few limiting nutrients better than all the others and its rate of
growth during the colonization process is at least equal to the
washout rate from the intestine (13, 14). The rate of growth of
a particular bacterium in the intestine is presumably deter-
mined by the nature of the limiting nutrient it utilizes, and the
density to which it grows is determined by the available con-
centration of that nutrient. It is also possible for a species that
does not compete well for limiting nutrients to avoid washout
and to colonize if it is able to adhere to the intestinal wall (14).
In recent studies, the location of a commensal strain, Esch-
erichia coli BJ4, was examined in the mouse large intestine
using in situ hybridization with species-specific rRNA probes
(37). E. coli BJ4 was found dispersed in intestinal mucus and in
luminal contents but was not found associated with epithelial
cells (21, 37). While E. coli is present in both mucus and
intestinal contents, a large body of experimental evidence
shows that it grows rapidly in intestinal mucus both in vitro and
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in vivo but does not grow or grows poorly in luminal contents
(23, 33, 45, 46, 49). Furthermore, E. coli leuX mutants have
difficulty surviving in intestinal mucus and eda mutants have
difficulty growing in intestinal mucus in vitro, and both are
unable to colonize the mouse large intestine (33, 46). It is
therefore highly likely that the ability of an E. coli strain to
grow and survive in intestinal mucus plays a critical role in its
ability to colonize the intestine. With this in mind, genes crit-
ical to the ability of E. coli to colonize the mouse large intestine
were identified by screening mutants unable to grow well on
agar plates containing mouse cecal mucus as the sole source of
carbon and nitrogen. These mutants were tested for the ability
to colonize the mouse large intestine. Surprisingly, the first
mutant we isolated was a lipopolysaccharide (LPS) core mu-
tant. In the present study, we characterize that mutant with
respect to its ability to grow and survive in cecal mucus and its
ability to colonize the mouse large intestine.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this
study are listed in Table 1.
Bacterial growth media. Luria broth was made as described by Revel (41).
Luria agar is Luria broth containing 12 g of Bacto Agar (Difco Laboratories,
Detroit, Mich.) per liter. MacConkey agar (Difco) was prepared according to the
package instructions. Glucose minimal M9 agar plates (Difco Agar Noble; 15
g/liter) were made with M9 minimal medium (30) supplemented with glucose
(0.2% [wt/vol]). Cecal-mucus agar plates (Difco Agar Noble; 15 g/liter) were
made using UV light-sterilized mouse cecal mucus (34) at a concentration of 2
mg/ml with respect to protein in HEPES-Hanks buffer (pH 7.4).
Insertional mutagenesis. E. coli MG1655 Strr Nalr mini-Tn5 Km (kanamycin)
mutants were constructed by insertional mutagenesis. Briefly, E. coli ATM161
carrying the suicide vector pUT, which contains the mini-Tn5 Km transposon
(10), was conjugated with the recipient E. coli MG1655 Strr Nalr in the following
manner. The donor and recipient strains were grown overnight, with shaking, in
Luria broth at 30°C. Aliquots of 100 liters of each culture were mixed together
in 5 ml of 10 mM MgSO4 and filtered through a Millipore 0.45-m-pore-size
membrane filter. The filter was placed on the surface of a Luria agar plate and
incubated for 5 h at 37°C. Following incubation, the bacteria on the filter were
suspended in 5 ml of 10 mM MgSO4, and 100-liter aliquots of the suspension
were plated on Luria agar (Difco) containing streptomycin sulfate (100 g/ml) and
kanamycin sulfate (40 g/ml) and incubated at 37°C overnight. The colonies were
then screened for the ability to grow on glucose (0.2% [wt/vol]) minimal M9 agar
plates containing streptomycin sulfate (100 g/ml) and kanamycin sulfate (40
g/ml) by toothpicking them and incubating them overnight at 37°C. Mutants that
grew on Luria agar and glucose minimal M9 agar were toothpicked to cecal-
mucus agar plates. The cecal-mucus agar plates were incubated at 37°C for 18 h.
Isolation of suppressor mutants. E. coli MD42 recipients, sensitive to0.1 mg
of sodium dodecyl sulfate (SDS)/ml, were mated with E. coli SM10  pir (pFAC)
as described above. pFAC houses the Himar1-based mini-mariner transposon
containing the aacC1 gentamicin resistance gene (50). Five hours after mating,
mutants (106) were plated on Luria agar plates containing streptomycin (100
g/ml), kanamycin sulfate (40 g/ml), gentamicin (15 g/ml), and SDS (1 mg/
ml). Following incubation at 37°C overnight, five MD42 SDS-resistant colonies
were isolated. Further characterization of the isolates is presented in Results.
Bacteriophage P1 transduction. Bacteriophage P1 transduction and curing of
transductants of bacteriophage P1 were performed as previously described (24).
The transductants were constructed by infecting E. coli MG1655 Strr with the P1
lysate from an induced Luria broth culture of lysogenized E. coli MD42 Strr Nalr
and selection on Luria agar containing streptomycin sulfate (100 g/ml) and
kanamycin sulfate (40 g/ml).
SDS, novobiocin, and bile salts sensitivity testing. SDS, novobiocin, and bile
salts sensitivity testing were performed essentially as described by Yethon et al.
(51). Briefly, twofold serial dilutions were made of SDS (200 to 0.1 mg/ml),
novobiocin (200 to 1.6 g/ml), and Bacto Bile Salts no. 3 (Difco) (6.0 to 0.18
mg/ml). Each series of tubes was inoculated with 105 CFU/ml from an over-
night culture of the strain to be tested and then incubated standing at 37°C.
Growth was scored as positive if, after 8 h of incubation, the absorbancy at 600
nm (A600) was 0.2.
In vitro growth in mouse cecal mucus. Mouse cecal mucus was isolated as
previously described (8). Briefly, 18 mice (35 to 42 days old) were fed Charles
River Valley Rat, Mouse, and Hamster Formula for 5 days. The drinking water
was then replaced with sterile distilled water containing streptomycin sulfate (5
g/liter). Twenty-four hours later, the mice were sacrificed by CO2 asphyxiation
and their ceca were removed. The cecal contents were collected for use in growth
experiments (see below), and any remaining cecal contents were washed out of
each cecum with sterile HEPES-Hanks buffer (pH 7.4). Viscous cecal mucus was
prepared from the washed ceca by scraping them with a rubber spatula as
described previously (8). The cecal mucus obtained from the mice was pooled
and mixed to obtain a homogeneous, highly viscous sample, which is undiluted
cecal mucus.
The ceca from each set of 18 mice yielded 2 ml of undiluted cecal mucus.
One-milliliter aliquots of undiluted cecal mucus or undiluted cecal contents were
separately inoculated with 105 CFU of either E. coli MG1655 Strr or E. coli
MD42. E. coli strains used for the inocula were grown in Luria broth (37°C;
shaking; 18 h), centrifuged at 8,000  g, washed three times in sterile HEPES-
Hanks buffer (pH 7.4), and diluted in HEPES-Hanks buffer (pH 7.4). Cecal-
mucus samples were incubated standing at 37°C. Samples were withdrawn at the
times indicated in the figures, diluted in HEPES-Hanks buffer (pH 7.4), and
plated on Luria agar plates containing either streptomycin sulfate (100 g/ml)
for MG1655 Strr or streptomycin sulfate (100 g/ml) and kanamycin sulfate (40
g/ml) for MD42. The plates were incubated at 37°C for 18 to 24 h prior to
bacteria being counted. Growth experiments utilizing cecal contents were per-
formed identically to those utilizing cecal mucus. Cecal mucus was also scraped
into HEPES-Hanks buffer (pH 7.4) and centrifuged and sterilized by UV irra-
diation as described previously (8, 33) and was adjusted to a concentration of 2
mg/ml with respect to protein using sterile HEPES-Hanks buffer (pH 7.4) as
described previously (33). The cecal mucus isolated from five mice yielded 30
mg of protein. The growth of E. coli MG1655 Strr and E. coli MD42 in cecal
mucus (2 mg/ml with respect to protein) was determined as described above for
undiluted cecal mucus. Alternatively, 1.0-ml aliquots were read at 600 nm in a
Pharmacia Biotech (Ultrospec 2000) UV–visible-light spectrophotometer.
TABLE 1. Bacterial strains and plasmids
Strain or
plasmid Relevant genotype or phenotype
Source or
reference
E. coli strains
MG1655 Wild type (CGSC no. 7740) E. coli Genetic
Stock
Culture
Collection;
Yale
University
MG1655
Strr
Spontaneous streptomycin-resistant
mutant of MG1655
This study
MG1655
Strr Nalr
Spontaneous nalidixic acid-resistant
mutant of MG1655 Strr
This study
MD42 Strr
Nalr
Mini-Tn5 Km::waaQ mutant of
MG1655 Strr Nalr
This study
MD42 P1 mini-Tn5 Km::waaQ
transductant of MD42 Strr
This study
MD42mm5 Mini-mariner Gm::bipA mutant of
MD42
This study
SM10  pir
(pFAC)
Contains mini-mariner Gm in the
pFAC suicide vector
50
ATM161 Contains mini-Tn5 Km in the pUT
suicide vector
10
F470 Rough LPS derivative of an
O8:K27 strain
51
CWG296 waaP::aacC1 mutant of F470 51
CWG297 waaQ::aacC1 mutant of F470 51
CWG303 waaG::aacC1 mutant of F470 52
Plasmids
pLD55 Suicide vector for allelic exchange;
bla tetAR
28
pBR322 bla tet 4
VOL. 71, 2003 A NONCOLONIZING E. COLI MG1655 waa MUTANT 2143
 o
n
 Septem
ber 19, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
Mouse colonization experiments. The method used to compare the large-
intestine-colonizing abilities of E. coli strains in mice has been described previ-
ously (24, 26, 33, 45, 46, 49). Briefly, three male CD-1 mice (5 to 8 weeks old)
were given drinking water containing streptomycin sulfate (5 g/liter) for 24 h to
eliminate resident facultative bacteria (28). Following 18 h of starvation, the mice
were fed 1.0 ml of 20% (wt/vol) sucrose containing either 5  105, 1  108, or 1
 1010 CFU of Luria broth-grown E. coli MG1655 strains, depending on the
experiment. After the bacterial suspension was ingested, both the food (Charles
River Valley Rat, Mouse, and Hamster Formula) and streptomycin-water were
returned to the mice, and 1 g of feces was collected after 5 and 24 h and, on
odd-numbered days, at the times indicated in the figures. The mice were housed
individually in cages without bedding and were placed in clean cages daily.
One-gram fecal samples (no older than 24 h) were homogenized in 1% Bacto
Tryptone (10 ml) and diluted in the same medium, and 100-l samples were
plated on Luria agar plates containing streptomycin sulfate (100 g/ml) and
kanamycin sulfate (40 g/ml) for determining numbers of MD42, streptomycin
sulfate (100 g/ml) for determining numbers of MG1655 Strr, kanamycin sulfate
(40 g/ml) and gentamicin (15 g/ml) for determining numbers of MD42 mm5
in feces of mice fed Luria broth-grown MD42 mm5, and kanamycin sulfate (40
g/ml) and SDS (1.0 mg/ml) for determining numbers of MD42 mm5 in feces of
mice fed MD42 mm5 grown in Luria broth containing SDS (1 mg/ml). All plates
were incubated for 18 to 24 h at 37°C prior to counting of bacteria. Each
colonization experiment was repeated at least once to confirm the initial colo-
nization results. The log10 mean number of CFU per gram of feces and the
standard error of the log10 mean number of CFU per gram of feces for each set
of three mice was calculated for each time point. The limit of detection of CFU
per gram of feces is 102. In one experiment, when the concentration of an E. coli
strain in mouse feces was below the detection limit on day 7, three mice were
sacrificed and their cecal mucus was isolated as described above. The mucus from
the cecum of each mouse (100 l) was plated onto Luria agar plates containing
the appropriate antibiotics to determine if the E. coli strain could be detected in
mouse cecal mucus.
DNA procedures and sequencing. The gene interrupted in MD42 was deter-
mined by sequencing out in one direction from the mini-Tn5 Km insertion. The
gene interrupted by the mini-mariner transposon in MD42 mm5 was determined
by sequencing out in both directions from the mini-mariner transposon. E. coli
MD42 and MD42 mm5 chromosomal DNAs were purified using Qiagen
Genomic tip-100. The 40-l sequencing reaction mixture contained 2 g of
chromosomal DNA, 13 pmol of primer (30-mer), and 16 l of BigdyeTM Ter-
minator Cycle Sequencing Ready Reaction mix. The PCR sequencing program
consisted of 5 min at 95°C; 10 cycles of 30 s at 95°C and 4 min 20 s at 65°C with
a 0.5°C decrease for each subsequent cycle; 10 cycles of 30 s at 95°C, 20 s at 60°C
with a 0.5°C decrease for each subsequent cycle, and 4 min 20 s at 60°C; 80 cycles
of 30 s at 95°C, 20 s at 55°C, and 4 min 20 s at 60°C; and cool down to 4°C.
Reaction products were purified three times over a Centriflex gel filtration
cartridge (Edge BioSystems). Samples were analyzed on the ABI 310 genetic
analyzer (Perkin-Elmer, Foster City, Cal.) by injection for 100 s. Up to 500 bases
could be read from a single run.
Sequence analysis was performed and the results were collected using ABI
Prism 310 collection software version 1.04 (Perkin-Elmer) and analyzed with
Sequence Analysis version 3.0 (Perkin-Elmer). Database searches were done
using BLAST (http://www.ncbi.nlm.nih.gov/).
The primers used to amplify part of the the pir gene (602 bp) were as follows:
forward, 5	-ATG AGA CTC AAG GTC ATG ATG G-3	, and reverse, 5	-CTC
TTC CTT TAA CTC ATC AAC GG-3	. The primers upstream and downstream
of waaQ, used to amplify a 4,000-bp fragment containing the mini-Tn5 Km
transposon in waaQ and flanking sequences, were as follows: forward, 5	-CTA
GCT GCA GGC TGA CTT ATG GAT GTG CTG GG-3	, and reverse, 5	-CTA
GCT GCA GCC CAC GAC TGT GTA TAT ACC CG-3	.
Allelic exchange. The bipA::mini-mariner transposon was inserted into a fresh
MD42 background by a modification of the system described by Datsenko and
Wanner (9). The forward primer, including a 5	 BamHI site, was 5	-CTA GGG
ATC CCA TCG TCA GTA CGT GTT CAG CG-3	, and the reverse primer,
including a 5	 BamHI site, was 5	-CTA GGG ATC CAT GAC TTT GCA GAT
AAT TGT GAC-3	. The primers were used to PCR amplify the
bipA::mini-mariner insertion flanked by a 399-bp region upstream of the bipA
ATG start codon and a 188-base region downstream of the bipA TGA stop
codon. The PCR product was used to transfect MD42 (pKD46) as described by
Datsenko and Wanner (9), and recombinants were selected at 37°C on Luria
agar plates containing kanamycin sulfate (40 g/ml) and gentamicin (15 g/ml).
The recombinants were tested for loss of pKD46 by growth at 37°C and testing
for loss of ampicillin resistance as described by Datsenko and Wanner (9).
Recombinants were confirmed by PCR to have the bipA::mini-mariner transpo-
son inserted correctly in the chromosome.
Isolation of LPS and gel electrophoresis. Luria broth-grown cells (3 ml) were
centrifuged, resuspended in 1.0 ml of phosphate-buffered saline, vortexed, and
then incubated at 60°C for 30 min. The suspension was centrifuged at 11,750 
g for 30 min. One hundred microliters of the supernatant was added to 100 l of
Tricine sample buffer (Bio-Rad Laboratories, Hercules, Calif.) containing 2-
-
mercaptoethanol (2%), and the mixture was boiled for 10 min. Fifty microliters
of the boiled sample was added to 10 l of a protease K solution (2.5 mg of
protease K in 1.0 ml of sample buffer), and the sample was then incubated at
60°C for 60 min and centrifuged at 16,000  g for 30 min. LPS in supernatants
from samples prepared in this manner was separated on 18% Tricine sodium
SDS-polyacrylamide gel electrophoresis (PAGE) gels as described by Pradel and
Schnaitman (38) and visualized by silver staining (48).
Motility. Motility assays were performed by inoculating 10 l of overnight
Luria broth cultures on the tops of 10-cm Luria soft-agar tubes (3.5 g of Bacto
Agar/liter). Migration toward the bottoms of the tubes was recorded after 24 h
of incubation at 37°C. In this assay, nonmotile mutants do not migrate.
Serotyping. Serotyping (O and H) was performed using specific antisera pro-
duced by the World Health Organization International Escherichia and Klebsiella
Centre, Statens Seruminstitut, Copenhagen, Denmark.
Assays for type 1 fimbriae. Type 1 fimbriation was assayed by slide agglutina-
tion using fresh guinea pig erythrocytes (5% suspension) in the presence and
absence of mannose (100 mM). Strains that have type 1 fimbriae agglutinate
guinea pig erythrocytes in the absence of mannose but not in its presence. Type
1 fimbriation was confirmed by agglutination with specific antibodies against type
1 fimbriae (20).
Preparation of histological sections for hybridization. After the mice were
sacrificed, the cecum was removed from each mouse and was cut in two halves.
One half was immediately transferred to a phosphate-buffered 4% (vol/vol)
formalin solution. The other half was used for determination of the number of
CFU per gram of cecum. Each cecum was dehydrated and embedded in paraffin
prior to preparation of 5-m-thick cross sections. The sections were placed on
glass microscope slides. Prior to hybridization, the sections were deparaffinated
by treatment (three times; 10 min each) with xylene (Bie & Berntsen, Rødovre,
Denmark) and dehydrated for 10 min in 96% ethanol. Before the hybridization
solution was applied, the intestinal sections were circumscribed with a hydro-
phobic PAP-pen (Daido Sangyo Co. Ltd., Tokyo, Japan).
Oligonucleotide probes. A probe specific to E. coli 23S rRNA (EC1531; 5	-
CAC CGT AGT GCC TCG TCA TCA-3	) was used (37). The probe was labeled
at the 5	 end with CY3 red fluorescent dye (cyanine dye CY3.29-OSu; Biological
Detection Systems, Pittsburg, Pa.). In addition, probe EU338 (44), which is
specific to the eubacterial 23S rRNA domain, was used. This probe (5	-GCT
GCC TCC CGT AGG AGT-3	) was labeled at the 5	 end with the green
fluorescent compound fluorescein (Peninsula Laboratories, Inc., Belmont, Cal-
if.).
Hybridization and microscopy. For visualization of bacteria in the intestinal
sections, the eubacterial probe labeled with fluorescein was used in combination
with the CY3-labeled E. coli-specific probe. Hybridization was carried out as
described by Poulsen et al. (37) with the following modifications. The hybridiza-
tion solution contained 10% formamide and 2.5 ng of each probe and was at pH
7.2. Washing solution I contained 10% formamide and was at pH 7.2. Washing
solution II was at pH 7.2. Following hybridization, the sections were viewed by
confocal microscopy.
RESULTS
Isolation and biochemical characterization of an MG1655
Strr Nalr mutant that grows poorly on cecal-mucus agar
plates. Three hundred mini-Tn5 Km mutants that grew on
both Luria agar plates and glucose M9 plates were toothpicked
from Luria agar to cecal-mucus agar plates (2 mg/ml with
respect to protein) containing streptomycin and kanamycin.
One mutant, designated MD42 Strr Nalr (for mucus defective),
grew poorly on the cecal-mucus agar plates, i.e., the colony
diameter was less than half that of the other mutants and
growth was relatively sparse. MD42 Strr Nalr was also ampi-
cillin sensitive, ruling out the possibility that pUT, the suicide
vector containing the mini-Tn5 Km transposon, had integrated
into the chromosome. Moreover, the pir gene did not amplify
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from MD42 Strr Nalr DNA using pir-specific primers (see Ma-
terials and Methods) but did amplify from DNA isolated from
E. coli ATM161, the mini-Tn5 Km donor strain. In addition,
MD42 Strr Nalr was transformable with pBR322 but was not
transformable with the pir-dependent suicide vector pLD55
(28). These results effectively rule out the possibility that
MD42 Strr Nalr became lysogenized with bacteriophage  pir
during mating, a reported possible pitfall (10). To be sure that
the growth defect of MD42 Strr Nalr on cecal-mucus agar
plates was due to the mini-Tn5 Km insertion, kanamycin re-
sistance was transduced from MD42 into MG1655 Strr. The
transductants had the same defective growth characteristics as
MD42 Strr Nalr on cecal-mucus agar plates, which proves that
the mini-Tn5 Km insertion in MD42 Strr Nalr was indeed
responsible for the growth defect. E. coli MG1655 Strr and one
of the MG1655 Strr transductants, which for simplicity will
hereafter be referred to as MD42, were chosen for further
study.
In addition to growing poorly on cecal-mucus agar plates,
MD42 grew poorly on MacConkey agar plates, suggesting that
it might be sensitive to bile salts. E. coli MG1655 Strr and
MD42 behaved identically in 36 of the 41 biochemical tests
listed in Table 5.3 of the 1984 edition of Bergey’s Manual of
Systematic Bacteriology (6) (the tests not performed were for
production of lipase, DNase, and phenylalanine deaminase
and for utilization of -methyl-D-glucoside and D-arabitol). In
addition, MG1655 Strr and MD42 were tested for motility and
production of type 1 fimbriae. MG1655 Strr and MD42 were
found to be identical with respect to all biochemical charac-
teristics. The serotype of both strains was OR:H48, i.e., both
were rough and both contained the H48 flagellar antigen, typ-
ical of K-12 strains. Furthermore, the strains contained approx-
imately equal amounts of type 1 fimbriae. MD42 was motile,
but less so than MG1655 Strr, i.e., MG1655 Strr traveled 6.5 
0.29 cm (n  3) down Luria soft-agar tubes in 24 h (see
Materials and Methods), whereas MD42 traveled only 3.8 
0.03 cm (n  3) in the same time.
The gene interrupted in MD42 is waaQ. DNA sequencing
(449 bp from the point of insertion) showed that the mini-Tn5
Km inserted 192 bp upstream of the 3	 end of the waaQ coding
sequence. The waaQ gene (1,035 bp) is the most upstream of
the 10 genes in the E. coli K-12 waa operon involved in assem-
bly of the LPS core (15). The mini-Tn5 Km transposon was the
only segment of the pUT suicide vector inserted, which was
confirmed by PCR using waaQ-specific upstream and down-
stream primers (see Materials and Methods). Using these
primers, the expected 4.0-kb fragment was amplified.
Sensitivity of MD42 to SDS, bile salts, and novobiocin. As
stated above, MD42 grew poorly on MacConkey agar plates,
which contain a mixture of bile salts. E. coli strains with severe
defects in the LPS core (“deep-rough” mutants) are known to
be hypersensitive to SDS, bile salts, and hydrophobic antibiot-
ics, such as novobiocin (51). Therefore, MD42 and MG1655
Strr were tested for sensitivity to these agents (see Materials
and Methods). As shown in Table 2, MD42 had a 1,000-fold
increase in sensitivity to SDS, a 8-fold increase in sensitivity
to bile salts, and an 33-fold increase in sensitivity to novo-
biocin compared to MG1655 Strr, suggesting that MD42 is a
deep-rough mutant.
LPS profiles of MG1655 Strr and MD42. LPS core mutants
defective only in waaQ are not deep-rough mutants, i.e., they
are not hypersensitive to bile salts, novobiocin, or SDS and
make an essentially full-length LPS core oligosaccharide (51,
52). However, the mini-Tn5 Km transposon used in the present
study has identical strong transcription termination sequences
flanking both ends of the kanamycin resistance gene (10). It
was therefore likely that the entire waa operon was inactive in
MD42 due to downstream polarity. Mutants in which the only
defective waa gene is waaG make a truncated LPS core oligo-
saccharide (52), and mutants in which the only defective waa
gene is waaP make both truncated and full-length LPS core
oligosaccharides (53). Therefore, to determine whether the
entire waa operon in MD42 was inactivated, the mobilities of
the LPS cores of MD42, a known waaQ mutant (51), a known
waaG mutant (51), and a known waaP mutant (51) were com-
pared on SDS-PAGE gels. As shown in Fig. 1, MD42 LPS core
migration was essentially identical to that of the truncated LPS
core of the waaG mutant and to that of the lower band of the
LPS core isolated from the known deep-rough waaP mutant,
and its migration was more rapid than those of the LPS cores
of the known waaQ mutant and MG1655 Strr. These data
suggest that the mini-Tn5 Km insertion inactivated the entire
MD42 waa operon.
Mouse large-intestine-colonizing ability of MD42. The
mouse large-intestine colonization model requires that the
mice be fed streptomycin in their drinking water. This treat-
ment eliminates the facultative flora and creates a niche for E.
coli but leaves the obligate-anaerobe population largely intact
(29). The mini-Tn5 Km insertion in MD42 had no effect on its
resistance to streptomycin (MIC  5.0 mg/ml). MG1655 Strr
and MD42 were each fed individually to mice (1010 CFU per
mouse). At 5 h postfeeding, MD42 was present in feces at 3.6
FIG. 1. E. coli LPS profiles. Purified LPS on SDS-PAGE gels was
silver stained as described in Materials and Methods. Lane 1, MG1655
Strr; lane 2, MD42; lanes 3 to 5, SDS-sensitive revertants isolated from
SDS-resistant MD42 mm5; lanes 6 to 8, individual SDS-resistant
MD42 mm clones; lane 9, waaG::aacC1 mutant of F470; lane 10,
waaP::aacC1 mutant of F470; lane 11, waaQ::aacC1 mutant of F470;
lane 12, wild-type F470.
TABLE 2. MICs of SDS, novobiocin, and bile salts for MG1655
Strr and MD42a
Strain
MIC
SDS
(mg/ml)
Novobiocin
(g/ml)
Bile
salts
(mg/ml)
MG1655 Strr 100 50 6.0
MD42 0.1 1.56 1.5
MD42mm5 (Luria broth) 0.1 6.25 1.5
MD42mm5 (Luria broth  SDS) 25 50 3.0
a MICs were determined as described in Materials and Methods.
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 109 CFU per g, and MG1655 Strr was present at 7.0  109
CFU per g. Therefore, the strains survived passage through the
intestine equally well, despite the fact that bile salts are present
in the small intestines of mammals at levels as high as 20 mM
(2). However, MG1655 Strr colonized at a level between 107
and 108 CFU per g of feces (Fig. 2), whereas MD42 decreased
in numbers continuously through day 5 and was observed only
sporadically (between 102 and 103 CFU per g of feces) there-
after (Fig. 2). Furthermore, in one experiment in which MD42
was undetectable in feces 7 days postfeeding in three mice fed
the strain, it was undetectable (1 CFU) in cecal mucus iso-
lated from the same mice sacrificed 8 days postfeeding,
whereas MG1655 Strr was present in cecal mucus isolated from
three mice sacrificed on the same day at an average level of 4.5
 106 CFU per cecum (data not shown).
When MD42 was fed to mice at lower levels (5  105 CFU
per mouse), it grew from a level of about 2.5  106 CFU per
g of feces 5 h postfeeding to 2.2  108 CFU per g of feces
24 h postfeeding (Fig. 2) but was eliminated thereafter, so that
by day 7 and beyond (up to day 15), MD42 was no longer
detectable in feces (102 CFU per g) (Fig. 2). It therefore
appears that MD42 grew in the intestine for 1 day in vivo and
then failed to grow at a rate sufficient to prevent washout from
the intestine. As a control, MG1655 Strr was fed to mice at 5
 105 CFU per mouse. It grew to a level of 5  108 CFU per
g of feces within 24 h postfeeding and colonized at a level of
between 107 and 108 CFU per g of feces until the experiment
was terminated at day 15 (data not shown).
Survival of MD42 in mouse feces. It might be argued that if
MD42 dies rapidly in mouse feces relative to MG1655 Strr,
fecal viable counts would minimize its real colonizing ability.
To address this question, samples of feces taken 24 h postfeed-
ing from a mouse fed 5  105 CFU of MD42 and samples of
feces taken 24 h postfeeding from a mouse fed 5 105 CFU of
MG1655 Strr were homogenized in 1% Bacto Tryptone imme-
diately after collection and plated, 24 h postcollection and
plated, and 48 h postcollection and plated. Both MD42 and
MG1655 Strr Nalr died logarithmically in mouse feces so that
every 24 h 5% of the live MD42 in feces remained viable,
whereas 35% of the live MG1655 Strr remained viable. Since
feces no older than 24 h are assayed for viable counts, at most
MD42 CFU relative to MG1655 Strr CFU are sevenfold un-
derestimated, which would not change the fact that MD42 is a
far worse colonizer of the mouse intestine than MG1655 Strr.
Growth of MG1655 Strr and MD42 in dilute cecal mucus.
Although MD42 grew poorly on cecal-mucus agar plates (2
mg/ml with respect to protein), when grown standing in liquid
cecal mucus at the same protein concentration, it grew as well
to stationary phase as MG1655 Strr (55-min generation times);
however, after overnight incubation, it settled to the bottom of
the culture tubes. As measured by A600, only 22.0%  2.2% (n
 3) of the MD42 cells in the overnight culture remained
suspended. In contrast, 59.5%  1.5% (n  3) of the MG1655
Strr cells in the culture remained suspended overnight. Micro-
scopic analysis of the MD42 cecal-mucus cultures revealed that
by the time the cells settled to the bottom of the culture tubes,
they had agglutinated, forming massive clumps (Fig. 3A).
When overnight MD42 cecal-mucus cultures were vortexed,
the cells in the clumps dispersed and the viable counts were
found to be 4.0  108 CFU/ml, suggesting that all the cells in
the clumps were viable. In contrast to MD42, overnight
MG1655 Strr cultures contained many small clumps but also
contained many single cells (Fig. 3B). MD42 grew with essen-
tially the same doubling time as MG1655 Strr in standing Luria
broth cultures (111 min for MG1655 Strr and 116 min for
MD42) and to nearly the same extent at 24 h of incubation (4
 108 to 8 108 CFU/ml). Neither strain formed clumps when
grown in Luria broth (Fig. 3C and D), and in each case, 60%
of the cells remained suspended overnight. In standing glucose
minimal-medium cultures, MG1655 Strr and MD42 grew with
identical generation times (110 min) and to nearly identical
extents (4  108 to 8  108 CFU/ml). MD42 did not aggluti-
nate in glucose minimal medium.
The NaCl concentration in HEPES-Hanks buffer is 137 mM,
which mimics the NaCl concentration in jejunal and ileal in-
testinal fluid (5). The NaCl concentration in Luria broth is 85.5
mM. Since deep-rough mutants have a more hydrophobic sur-
face than their wild-type counterparts, it was possible that the
increased NaCl concentration in HEPES-Hanks buffer was
responsible for MD42 agglutination. Therefore, cecal mucus (2
mg/ml with respect to protein) was prepared in HEPES-Hanks
buffer containing 85.5 and 137 mM NaCl. After overnight
growth in cecal mucus with 85.5 mM NaCl, 60.2%  0.8% (n
 3) of the MD42 cells remained suspended, whereas in the
presence of 137 mM NaCl, only 15.1%  1.8% (n  3) of the
MD42 cells remained suspended. It therefore appears that the
NaCl concentration in HEPES-Hanks buffer, representative of
FIG. 2. E. coli MG1655 Strr and MD42 colonization of the mouse
large intestine. Sets of three mice were fed either 1010 CFU of
MG1655 Strr (F), 1010 CFU of MD42 (Œ), or 5  105 CFU of MD42
(). At the indicated times, fecal samples were homogenized, diluted,
and plated as described in Materials and Methods. Bars representing
the standard error of the log10 mean number of CFU per gram of feces
for each set of three mice are presented for each time point.
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that in intestinal juice (5), is responsible for agglutination of
MD42 after growth in diluted cecal mucus.
Growth of MG1655 Strr and MD42 in undiluted cecal mu-
cus and in cecal contents. MG1655 Strr and MD42 were also
tested separately for growth during a 42-h period in cecal
mucus scraped directly into culture tubes. Each strain was
inoculated at a concentration of 5  105 CFU/ml. Both
MG1655 Strr and MD42 grew rapidly in undiluted cecal mucus
to viable counts of 2.0  109 and 7.0  108 CFU/ml, respec-
tively, at 24 h postinoculation, and each stabilized at a level of
108 CFU/ml (Fig. 4A). It therefore appears that there is no
antimicrobial substance, e.g., bile salts, present in mouse cecal
mucus at high enough concentrations to preferentially kill
MD42.
E. coli MG1655 Strr and MD42 were also each inoculated at
5  105 CFU/ml into cecal luminal contents isolated directly
from mouse intestines (Fig. 4B). Both MD42 and MG1655 Strr
remained relatively constant in number in cecal contents for
6 h postinoculation. After 6 h, both strains began to die at
approximately the same rate (Fig. 4B). Therefore, both MD42
and MG1655 Strr failed to grow in cecal luminal contents, and
each had about the same sensitivity to antimicrobials present in
cecal contents. The failure of various E. coli strains to grow in
cecal luminal contents has been reported previously (25, 33, 45,
46, 49).
Visualization of MD42 in the mouse cecal-mucus layer. Ex-
periments were performed to determine whether MD42 agglu-
tinated in cecal mucus in vivo as it did in diluted mouse cecal
mucus in vitro. MD42 and MG1655 Strr were grown in Luria
broth, conditions under which the majority of MD42 and
MG1655 Strr appear as single cells (Fig. 3C and D), and fed to
mice individually (1010 CFU per mouse). The colonized bac-
teria were visualized in cecal mucus in situ 24 h postfeeding by
hybridization with an E. coli-specific oligonucleotide probe
(see Materials and Methods). MD42 was present in cecal mu-
cus almost exclusively in small clumps ranging between 4 and
20 cells far from epithelial cells (Fig. 5B), whereas MG1655
Strr was present in cecal mucus almost exclusively as single
FIG. 3. Phase-contrast microscopy of MD42 and MG1655 Strr cultures. The cultures were grown standing either in Luria broth or in mouse
cecal mucus (2.0 mg/ml with respect to protein). After 24 h of incubation, 10-l samples were taken from the bottoms of the unvortexed culture
tubes and were examined by phase-contrast microscopy. (A) MD42 grown in cecal mucus; (B) MG1655 Strr grown in cecal mucus; (C) MD42
grown in Luria broth; (D) MG1655 Strr grown in Luria broth.
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cells, frequently close to epithelial cells (Fig. 5A). These results
suggest that MD42 may have difficulty penetrating the mucus
layer. In addition, the MD42 clumps were frequently associ-
ated with clumps of other eubacteria (Fig. 5B), suggesting the
possibility that MD42 is attracted to other hydrophobic bacte-
ria in vivo that may also have trouble penetrating the mucus
layer. In summary, these data show that in contrast to MG1655
Strr, MD42 forms clumps when grown in cecal mucus in vivo as
FIG. 4. Growth of MD42 and MG1655 Strr in undiluted viscous mouse cecal mucus and cecal contents. E. coli MG1655 Strr and MD42 were
inoculated separately at5 105 CFU/ml into 2 ml of mouse cecal mucus scraped directly into 14- by 110-mm culture tubes and into 2 ml of cecal
contents in 14- by 110-mm culture tubes. The cultures were incubated standing at 37°C. At the indicated times, the cultures were vortexed gently
and 50-l samples were diluted and plated. Bars representing the standard error of the log10 mean of duplicate cultures for each point are
presented. (A) Œ, MG1655 Strr in cecal mucus; ‚, MD42 in cecal mucus. (B) , MG1655 Strr in cecal contents; , MD42 in cecal contents.
FIG. 5. In situ hybridization with fluorescence-labeled oligonucleotide probes. Cecal-mucosal sections from mice fed MG1655 Strr (A) or
MD42 (B) were hybridized 24 h postfeeding with an E. coli-specific oligonucleotide probe (red) and a eubacterium-specific oligonucoeotide probe
(green). E. coli cells appear red, while all other bacteria appear green. Ep, epithelial cell. Bars, 10 m.
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well as in cecal mucus in vitro, thus suggesting that clumping
may play a role in its elimination from the intestine.
Isolation of an MD42 suppressor mutant. MD42 was mu-
tagenized with a mini-mariner transposon containing the gen-
tamicin resistance gene (50). Following mutagenesis and plat-
ing (see Materials and Methods), five MD42 colonies grew on
Luria agar plates containing streptomycin, kanamycin, genta-
micin, and SDS (1 mg/ml). Four of the isolates were far more
resistant to SDS (50 mg/ml) and novobiocin (50 g/ml) than
MD42. However, as shown by PCR, in each of these isolates
the mini-Tn5 Km transposon had moved out of the waaQ gene,
presumably because of the transposase introduced with the
mini-mariner transposon (not shown). These four isolates were
therefore not suppressor mutants and were not studied further.
The fifth isolate, designated MD42 mm5 (for mini-mariner),
retained the mini-Tn5 Km transposon in waaQ and was used
for further study.
Sequencing from both ends of the mini-mariner transposon
revealed that the transposon had inserted within the bipA
(yihK) gene, just 35 bp upstream of the 3	 end. bipA mutants
have been reported to grow poorly at 20°C (35) and to be more
motile than their parents (11); however, we were unable to find
any difference in doubling times at 20°C or in motility between
MD42 and MD42 mm5, suggesting that the bipA gene in
MD42 mm5 was not completely inactivated.
The LPS core mobility of MD42 mm5 on SDS-PAGE gels
remained like that of a deep-rough mutant, i.e., indistinguish-
able from that of MD42 and faster than that of MG1655 Strr
(Fig. 1). Furthermore, MD42 mm5 grew at the same rate and
almost to the same extent as MG1655 Strr in Luria broth, and
like MD42, MD42 mm5 agglutinated when grown in cecal
mucus (2 mg/ml with respect to protein) containing 137 mM
NaCl. These results suggest that MD42 mm5 grown in Luria
broth retained the defect in its core LPS.
Further characterization of MD42 mm5. The defective bipA
gene was introduced into a fresh MD42 background by allelic
exchange (see Materials and Methods), and three recombi-
nants were selected on Luria agar plates containing kanamycin
and gentamicin. All three recombinants were confirmed by
PCR as having the mini-mariner insertion in bipA. MD42 mm5
and the three recombinants grew well in Luria broth contain-
ing SDS (1.0 mg/ml), whereas MD42 did not. Therefore, the
mini-mariner insertion in bipA appears to be responsible for
increased MD42 mm5 resistance to SDS.
Although the resistance of MD42 mm5 to novobiocin (6.25
g/ml) was greater than that of MD42 (1.56 g/ml), surpris-
ingly, the MIC of SDS for MD42 mm5 did not differ signifi-
cantly from that for MD42 (Table 2). However, the increased
resistance of MD42 mm5 to SDS was found to manifest itself
as an increased number of resistant cells in the population (1
in 104 CFU) relative to MD42 (1 in 108 CFU) rather than an
increase in resistance of the entire population; MD42 mm5
had a 104 plating efficiency on Luria agar containing SDS (1.0
mg/ml) relative to Luria agar, whereas MD42 had a plating
efficiency of 108 under the same conditions. Moreover,
when MD42 mm5 was grown in Luria broth containing SDS, its
resistance to SDS increased 250-fold, its resistance to novo-
biocin increased 8-fold, and its resistance to bile salts increased
2-fold (Table 2).
To further investigate SDS sensitivity and resistance in
MD42 mm5, a single MD42 mm5 colony from a Luria agar
plate containing SDS (1 mg/ml) was grown overnight in Luria
broth containing SDS (1 mg/ml) and then plated on Luria agar
without SDS. After overnight incubation, 200 colonies were
toothpicked to two Luria agar plates containing SDS (1 mg/ml)
and then to a Luria agar plate without SDS. One hundred
eighty-nine colonies grew on all three plates, and 11 colonies
failed to grow on either of the two plates containing SDS but
grew well on the plate lacking SDS. Therefore, SDS-resistant
MD42 mm5 cells can revert to the SDS-sensitive state at the
relatively high frequency of 1 in 20. Thus, MD42 mm5 ap-
pears to be capable of a reversible switch between SDS sensi-
tivity and resistance: when grown under nonselective condi-
tions (without SDS), only 1 in 104 cells is resistant; conversely,
after being grown under selective conditions in which all cells
are SDS resistant, 1 in 20 cells reverts to being SDS sensitive
under nonselective conditions.
MD42 mm5 cells (1 in 104 resistant to SDS) grown in Luria
broth and in Luria broth containing SDS (1.0 mg/ml) were
diluted into cecal mucus (2.0 mg/ml with respect to protein) to
a level of 1.0  105 CFU/ml. The cultures were incubated
standing for 24 h at 37°C. After overnight growth in cecal
mucus, 66.3% 3.6% (n 3) of the MD42 mm5 cells that had
been grown in the presence of SDS remained suspended,
whereas only 25.8%  1.8% (n  3) of the MD42 cells grown
in Luria broth remained suspended. It therefore appears that
growth in the presence of SDS prevents excessive MD42 mm5
clumping in cecal mucus.
Since growth of MD42 mm5 in SDS prevented clumping in
cecal mucus, experiments were performed to compare the LPS
core structures of MD42 mm5 grown in Luria broth and that
grown in Luria broth containing SDS (1 mg/ml). Three SDS-
resistant clones and three SDS-sensitive clones that had re-
verted from SDS resistance were tested. The MD42 mm5 LPS
cores derived from the three SDS-resistant clones were the
same size as that of the wild type (Fig. 1); however, the LPS
cores derived from the three SDS-sensitive clones that had
reverted from SDS resistance were truncated (Fig. 1). Since
the SDS-resistant MD42 mm5 clones still contained the mini-
Tn5 Km insertion in waaQ, these results suggest that in these
clones, the mini-mariner insertion in bipA somehow restored
expression of the waa operon downstream of waaQ or induced
an alternative pathway for core synthesis.
Mouse large-intestine-colonizing ability of MD42 mm5.
Three mice were fed 108 CFU of MD42 mm5 that had been
grown in Luria broth (1 in 104 CFU resistant to SDS), and
three mice were fed 108 CFU of MD42 mm5 that had been
grown in Luria broth containing 1.0 mg of SDS/ml. MD42 mm5
grown in Luria broth acted identically to MD42, i.e., it initially
grew but then was rapidly eliminated from the intestine (Fig.
6). In contrast, after an initial period of growth in the intestine,
MD42 mm5 grown in the presence of SDS remained at rela-
tively high levels in the intestine and was only slowly eliminated
(Fig. 6). Therefore, making the entire MD42 mm5 population
resistant to SDS by growing it in the presence of SDS resulted
in partial suppression of poor colonizing ability. PCR analysis
of colonies from fecal plate counts indicated that the transpo-
son insertions in waaQ and bipA remained intact, ruling out the
possibility that the mutants reverted during the experiment. It
therefore appears that the better colonizing ability of MD42
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mm5 grown in the presence of SDS is due to suppression of the
deep-rough phenotype by the transposon insertion in bipA.
DISCUSSION
A large body of experimental evidence shows that E. coli
grows rapidly in intestinal mucus both in vivo and in vitro but
does not grow, or grows poorly, in luminal contents (23, 33, 45,
46, 49). This suggests that the ability of an E. coli strain to grow
in intestinal mucus plays a critical role in its ability to colonize
the intestine. In the present study, we isolated MD42, a mutant
in which the mini-Tn5 Km transposon had inserted in the
waaQ gene. MD42 grew poorly on cecal-mucus agar plates and
was unable to colonize the mouse large intestine.
The waaQ gene is the promoter-proximal gene in a 10-gene
operon involved in LPS core biosynthesis (15). WaaQ appears
to be a HepIII (Hep, L-glycero-D-manno-heptose) transferase
that transfers HepIII to the HepII residue in the LPS core (51).
However, since the mini-Tn5 Km transposon used here has
identical strong transcription termination sequences flanking
both ends of the kanamycin resistance gene (10), the entire
waa operon would likely be inactivated due to downstream
polarity. In support of this view, the LPS mobility on SDS-
PAGE gels was like that of a waaG mutant with a truncated
LPS core oligosaccharide and not like that of a nonpolar waaQ
mutant, which has a more complete LPS core oligosaccharide
(Fig. 1) (15, 51). waaG is immediately downstream of waaQ
(15). Inactivation of the entire waa operon results in a trun-
cated LPS core oligosaccharide, no HepIII, and lack of phos-
phorylation of HepI and HepII (51, 52, 53). Lack of phosphor-
ylation of HepI and HepII prevents neighboring LPS
molecules in the outer membrane from being cross-linked by
divalent cations (15, 51, 52, 53), resulting in extreme destabi-
lization of the outer membrane and a phenotype called deep-
rough (51, 52, 53). Deep-rough mutants exhibit hypersensitiv-
ity to bile salts, SDS, and the hydrophobic antibiotic
novobiocin (51). MD42 is also hypersensitive to all three
agents (Table 2), whereas a nonpolar E. coli waaQ mutant is
almost as resistant to SDS and novobiocin as its parent (51).
Therefore, it appears highly likely that in MD42, the insertion
in waaQ has a polar effect on the entire waa operon, thereby
explaining its deep-rough phenotype and its truncated core
oligosaccharide.
To our knowledge, this is the first time that an LPS deep-
rough core mutant has been shown to be unable to colonize the
intestine when fed to mice alone; however, various LPS mu-
tants have been shown to have a reduced mouse intestine-
colonizing ability when fed simultaneously with their wild-type
parents (7, 22, 26, 27). It should be noted, however, that not all
LPS mutants are poor colonizers when fed to mice alone, e.g.,
Salmonella enterica serovar Typhimurium O side chain mutants
and Vibrio cholerae O side chain mutants have been shown to
colonize the mouse large intestine well under these conditions
(3, 26). In fact, E. coli MG1655 Strr, the parent of MD42, has
no O side chain (34) yet, as shown here, is an excellent colo-
nizer when fed to mice alone.
Despite MD42 being hypersensitive to SDS and bile salts, it
is unlikely that antimicrobials present in cecal mucus are re-
sponsible for the inability of MD42 to colonize the mouse large
intestine, since MD42 and MG1655 Strr grew and survived
equally well in undiluted cecal mucus in vitro (Fig. 4). It might
be argued that MD42 is unable to colonize the mouse large
intestine because it is less motile than MG1655 Strr and may
therefore have trouble maintaining itself in the mucus layer.
This hypothesis is also unlikely, however, since it was shown
previously that nonmotile and nonchemotactic mutants of E.
coli F-18, a human commensal fecal isolate, are excellent col-
onizers of the mouse large intestine when fed to mice alone or
together with their parent (25).
The propensity of MD42 to form clumps may be a major
factor in its poor colonizing ability. That is, MD42 formed
clumps when grown in cecal mucus in vitro (Fig. 3) and in vivo
(Fig. 5) and failed to colonize the mouse large intestine (Fig.
2). Similarly, MD42 mm5 grown in Luria broth formed clumps
when grown in mouse cecal mucus in vitro and also failed to
colonize the mouse large intestine (Fig. 6). In contrast, when
grown in the presence of SDS, MD42 mm5 did not clump when
subsequently grown in cecal mucus in vitro and colonized the
mouse large intestine far better than either MD42 mm5 grown
in Luria broth (Fig. 6) or MD42 (Fig. 2). It was shown previ-
ously that the ability of S. enterica serovar Typhimurium to
traverse a layer of mucus in vitro and in vivo correlates well
with its ability to colonize the mouse large intestine (22, 26). It
FIG. 6. E. coli MD42 mm5 colonization of the mouse large intes-
tine. Sets of three mice were fed either 108 CFU of MD42 mm5 grown
in Luria broth (Œ) or 108 CFU of MD42 mm5 grown in Luria broth
containing SDS (1 mg/ml) (). At the indicated times, fecal samples
were homogenized, diluted, and plated on Luria agar plates containing
kanamycin sulfate (40 g/ml) and gentamicin (15 g/ml) for determin-
ing numbers of MD42 mm5 in feces of mice fed Luria broth-grown
MD42 mm5 and on Luria agar plates containing kanamycin sulfate (40
g/ml) and SDS (1.0 mg/ml) for determining numbers of MD42 mm5
in feces of mice fed Luria broth plus SDS-grown MD42 mm5. Bars
representing the standard error of the log10 mean number of CFU per
gram of feces for each set of three mice are presented for each time
point.
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is likely that, relative to single cells, clumps of cells have dif-
ficulty penetrating a layer of mucus. It may be that clumps of
MD42 cells are more readily sloughed into the cecal contents
as the mucus layer normally turns over and is excreted in the
feces. In summary, the results show a correlation between
clumping of the waaQ mutant and poor colonization; suppres-
sion of the clumping phenotype by mutation of bipA partially
restored colonization.
MD42 mm5 is a bipA mutant of MD42. Most of the prop-
erties ascribed to the E. coli BipA protein stem from studies
with enteropathogenic E. coli (EPEC) strains. BipA appears to
be important for several aspects of EPEC infection, including
resistance to the host bactericidal–permeability-increasing pro-
tein, for triggering characteristic rearrangements of the cy-
toskeletons of EPEC-infected host cells, for regulating flagel-
lum-mediated cell motility (11), and for expression of K-5
capsular genes (42). In addition, the E. coli K-12 BipA protein
appears to be important for achieving maximum growth rate at
low temperature (35). BipA is a member of the GTPase su-
perfamily, which includes the elongation factors EF-Tu and
EF-G and the TetM/TetO tetracycline resistance proteins (40).
BipA may also bind to ribosomes (40). The EPEC BipA pro-
tein is phosporylated on a tyrosine residue, but the K-12 BipA
protein is not phosphorylated (11). BipA regulates E. coli tar-
get gene expression by an as-yet-unknown mechanism.
Surprisingly, the LPS core of SDS-resistant MD42 mm5 was
not truncated (Fig. 1). This result suggests that although SDS-
resistant MD42 mm5 still contains a kanamycin resistance gene
with transcription termination sequences inserted in waaQ, the
downstream genes of the operon are somehow transcribed.
This would explain the normal-size LPS core; resistance to
SDS, bile salts, and novobiocin; and improved colonizing abil-
ity of MD42 mm5. At the present time, it is unclear how the
mini-mariner insertion in bipA would allow transcription of the
entire waa operon in SDS-resistant MD42 mm5, but it appears
that the mutant BipA protein prevents transcription termina-
tion caused by the mini-Tn5 Km insertion in waaQ or that the
mini-mariner insertion results in activation of a promoter im-
mediately upstream of waaG. It is also interesting that the
mini-mariner insertion in bipA eliminates only 11 amino acids
at the carboxyl-terminal end of the protein and that 5 of the
last 6 are basic amino acids. The short (11-amino-acid) trun-
cation of BipA in the MD42 background did not confer the
reported phenotype of a bipA null mutant: increased motility
and poor growth at 20°C. The bipA mutation in MD42 mm5
instead conferred restored synthesis of the LPS core (and
related sensitivity phenotypes), but with a pattern reminiscent
of phase variation (16, 19, 47), in this case between SDS sen-
sitivity and resistance. Thus, it appears that the truncated bipA
gene has altered regulation of genes that are important for
colonization. It will be interesting to determine if BipA is
either directly or indirectly involved in a phase variation mech-
anism that regulates E. coli MG1655 LPS core synthesis.
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